References
- Allegra E, Puzzo L, Cutrona D, Trichini A, Garozzo A, Serra A. p53 overexpression on the resection margins as a marker of local recurrence in glottic T1a carcinoma. Acta Otorhinolaryngol Ital 2003;23:454–8.
- Brandenburg JH. Laser cordectomy versus radiotherapy: an objective cost analysis. Ann Otol Rhinol Laryngol 2001;110:312–18.
- Spayne JA, Warde P, O’Sullivan B, Payne D, Liu FF, Waldron J, et al. Carcinoma in situ of the glottic larynx: results of treatment with radiation therapy. Int J Radiat Oncol Biol Phys 2001;49:1235–8.
- Dolcetti R, Doglioni C, Maestro R, Gasparotto D, Barzan L, Pastore A, et al. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 1992;52:178–82.
- Farhadieh RD, Smee R, Rees CG, Salardini A, Eggleton S, Yang JL, et al. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck. Aust N Z J Surg 2009;79:48–54.
- Geisler SA, Olsham AF, Weissler MC, Cai J, Funkhouser WK, Smith J, et al. p16 and p53 expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 2002;8:3445–53.
- Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, et al. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 1998;82:2159–65.
- Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP. Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 1998;82:286–91.
- Yuen PW, Lam KY, Choy JT, Ho WT, Wei WI. Clinicopathological significance of p53 and p21 expression in the surgical treatment of laryngeal carcinoma. Anticancer Res 2000;20:4863–6.
- Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, et al. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 2003;113:167–72.
- Jeannon JP, Soames J, Lunec J, Awwad S, Ashton V, Wilson JA. Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer. Clin Otolaryngol 2000;25:23–7.
- Nakashima T, Wang XF, Masuda M, Inokuchi A, Komiyama S. Overexpression of p53 nuclear protein in premalignant and malignant laryngeal lesions. Eur Arch Otorhinolaryngol 1999;256:56–9.
- Rowley H, Roland NJ, Helliwell TR, Caslin A, Kinsella AR, Jones AS. p53 protein expression in tumours from the head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin Otolaryngol 1998;23:57–62.
- Sittel C, Ecke HE, Damm M, von Pritzbuer E, Kvasnicka HM. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 2000;110:1012–17.
- Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 2005;262:890–8.
- Brandwein M, Zhang DY. “Molecular margins”: a better measure? Arch Otolaryngol Head Neck Surg 1998;124:841–2.
- Sidransky D, Boyle J, Koch W. Molecular screening. Prospects for a new approach. Arch Otolaryngol Head Neck Surg 1993;119:1187–90.
- Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope 2002;112:2129–40.
- Yi HJ, Zhang BQ, Guo W, Zhao LD, Yang SM. The role of molecular margins as prognostic factors in laryngeal carcinoma in Chinese patients. Acta Otolaryngol 2012;132:874–8.
- Nathan CO, Sanders K, Abreo FW, Nassar R, Glass J. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res 2000;60:3599–604.